Zachary Garbutt
About Zachary Garbutt
Zachary Garbutt is a Validation Engineer at Bristol Myers Squibb and a CQV II Engineer at IPS-Integrated Project Services, with a background in computer science and engineering.
Current Positions
Zachary Garbutt currently holds dual roles in the engineering sector. He serves as a Validation Engineer at Bristol Myers Squibb, a leading pharmaceutical company, and as a CQV II Engineer at IPS-Integrated Project Services. His responsibilities in these roles revolve around ensuring the compliance and validation of engineering processes and projects, a critical task in the pharmaceutical industry.
Previous Experience in Technology Sector
Before transitioning to validation engineering, Zachary Garbutt gained experience in the technology sector. He worked at HCL Technologies as a Junior Software Developer for 8 months from 2020 to 2021. Prior to that, he served as a Software Consultant for one year from 2019 to 2020 in the United States. These positions provided him with a solid foundation in software development and consulting.
Experience at Merck
Zachary Garbutt accumulated significant experience at Merck, a major pharmaceutical company. From 2019 to 2021, he worked as a Validation Engineer for two years, ensuring that products meet required standards and regulations. Concurrently, he also served as a Senior Support Engineer from 2019 to 2020 for one year, where he provided technical support and solutions for complex engineering problems.
Education and Computer Science Background
Zachary Garbutt holds a Bachelor's degree in Computer Science from Montclair State University, where he studied from 2017 to 2019. Before that, he attended Bergen Community College from 2015 to 2017. This educational background underpins his technical acumen and ability to bridge roles in both the technology and engineering sectors.
Career Transition to Validation Engineering
Zachary Garbutt transitioned from software development to validation engineering in 2019. His roles since then have focused on ensuring that engineering projects and processes comply with industry standards and regulations, particularly in the pharmaceutical sector. This shift has allowed him to leverage his computer science skills in a new and critical domain.